XML 27 R13.htm IDEA: XBRL DOCUMENT v3.22.4
Note 5 - Inventory
 12 Months Ended
Dec. 31, 2022
Inventory Disclosure [Abstract]  
Inventory Inventory At December 31, 2022 and 2021, the Company’s inventory primarily related to ORLADEYO. Additionally, inventory included RAPIVAB and peramivir, which is manufactured for the Company’s partners.
The Company’s inventories consisted of the following (in thousands):
December 31,
20222021
Raw materials$8,906 $5,658 
Work-in-process14,990 9,669 
Finished goods4,814 709 
Total inventory$28,710 $16,036 
Reserves(1,177)(245)
Total inventory, net$27,533 $15,791